SavedAdd your journal

Journals / Marmara Medical Journal / 2001 / Cilt: 14 - Sayı: 4

GENETIC ALTERATIONS OF ANDROGEN RECEPTOR GENE AND P53 BY FLUORESCENCE, IN SITU HYBRIDIZATION AND IMMUNODETECTION OF BCL-2 IN PROSTATIC INTRAEPITHELIAL NEOPLASIA AND CARCINOMA

HANDAN KAYA
İlter GÜNEY
Çiğdem ÇELİKEL
Levent TÜRKERİ
Atıf AKDAŞ
Sevgi KÜLLÜ
Pages
207–212
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Also, immunohistochemistry was used to search for bcl-2 expression.Results: Of the 18 cases studied by FISH, it was found that in benign areas AR gene amplification was 78% (14/18) and 100% disomy with wild type p53, in PIN areas AR gene amplification was 33% (6/18), p53 amplification 28% (5/18), in carcinomas AR gene amplification was 39% (7/18), and p53 amplification 28% (5/18).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: p53 and androgen receptor gene changes and bcl-2 expression in prostatic intraepithelial neoplasia (PIN) and adenocarcinoma were studied.
📊
Key Findings & Data:The genetic associations of PIN and adenocarcinoma as detected by FISH and immunohistochemistry were discussed.Material and Method: The study group consisted of 18 prostate cancer cases treated by radical prostatectomy.
💡
Conclusion & Impact:Also, immunohistochemistry was used to search for bcl-2 expression.Results: Of the 18 cases studied by FISH, it was found that in benign areas AR gene amplification was 78% (14/18) and 100% disomy with wild type p53, in PIN areas AR gene amplification was 33% (6/18), p53 amplification 28% (5/18), in carcinomas AR gene amplification was 39% (7/18), and p53 amplification 28% (5/18).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: p53 and androgen receptor gene changes and bcl-2 expression in prostatic intraepithelial neoplasia (PIN) and adenocarcinoma were studied. The genetic associations of PIN and adenocarcinoma as detected by FISH and immunohistochemistry were discussed.Material and Method: The study group consisted of 18 prostate cancer cases treated by radical prostatectomy. The p53 and androgen receptor gene changes at chromosomal level were studied using the FISH technique. Also, immunohistochemistry was used to search for bcl-2 expression.Results: Of the 18 cases studied by FISH, it was found that in benign areas AR gene amplification was 78% (14/18) and 100% disomy with wild type p53, in PIN areas AR gene amplification was 33% (6/18), p53 amplification 28% (5/18), in carcinomas AR gene amplification was 39% (7/18), and p53 amplification 28% (5/18). We observed the bcl-2 immunexpression mainly in basal ductal cells in benign, PIN and carcinoma areas.Conclusion: The results of our study suggest that AR gene amplification is significantly higher in benign areas compared to carcinomatous foci and that the presence of AR gene amplification is associated with the tumour stage. PIN is the most likely precursor of prostatic carcinoma.Key Words: Androgen receptor gene, p53, FISH, Prostate carcinoma

🔖

Cite This Article

KAYA, H., GÜNEY, İ., ÇELİKEL, Ç., TÜRKERİ, L., AKDAŞ, A., KÜLLÜ, S. (2001). GENETIC ALTERATIONS OF ANDROGEN RECEPTOR GENE AND P53 BY FLUORESCENCE, IN SITU HYBRIDIZATION AND IMMUNODETECTION OF BCL-2 IN PROSTATIC INTRAEPITHELIAL NEOPLASIA AND CARCINOMA. Marmara Medical Journal, Cilt: 14 - Sayı: 4, 207–212. https://ajindex.com/articles/284193

References (8)

  1. Bostwick DG. The pathology of incidental carcinoma. Cancer Surveys 1995;23:7-17.
  2. Humphrey PA, Walther PJ. Adenocarcinoma of the prostate. Am J Clin Pathol 1993; 100:256- 269. Bostwick DG. High grade prostatic intraepthelial neoplasia. Cancer:75:1823-1826.
  3. Barretton GB, Vogt T, Blasenbreu X, Lôhrs U. Comparison of DHA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: an image cytometric study. Hum Pathol 1994:25:506- 513. Qi-Long L, Abel P, Poster C, Lalani E. bcl-2 role in epithelial differentiation and oncogenesis. Hum Pathol 1996:27:102-110. Colombel !4, Symmans P, Gil S, et al. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone refractory human prostate cancers. Am J Pathol 1993;143:390-400.
  4. Taniguchi J, Moriyama H, Puri mo to S, Pameyama S, Paw a be P. Histochemical detection of intranuclear DHA fragmentation and its relation to the expression of be 1-2 oncoprotein in human prostatic cancer. Br J Urol 1996;77:719-723. Arnold JL. Tumor suppressor genes. In: Mendelsohn J, Howley PM, Israel MA, Liotta LA, eds. The molecular basis of cancer. Philadelphia: W.B. Saunders, 1995:86-101.
  5. Persons DL, Takai P, Gibney DJ, Patzmann JA, Lieber MM, Jenkins RB. Comparison of fluorescence in situ hybridization with flow cytometry and static image analysis in ploidy analysis of paraffin embedded prostate adenocarcinoma. Hum Pathol 1994;25:678- 683. Handan Kaya, el al Brown JA, Alcaraz A, Kakahashi S, Persons DL, Lieber MPI, Jenkins RB. Chromosomal aneusomies detected by fluorescence in situ hybridization analysis in clinically localised prostate carcinoma. J Urol ¡994,152:1157- 1 162. C^ian J, Bostwick DG, Takashi S, et al. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 1995; 15:5408-5414. Wilding G. Endocrine control of prostate cancer. Cancer Surveys 1995:23:45-62.
  6. Qian J, Jenkins RB, Bostwick DG. Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. J Pathol 1999:35:479-483.
  7. Takeda PI, Akakura R, Masai M, Akimoto S, Yatani R. Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinoma. Cancer 1996:77:934-940.
  8. Mydlo Jfl, Krai JG, Volpe M, Axotis C, Macchia RJ, Pertsvhuk LP. An analysis of microvessel density, androgen receptor, p53 and Her- 2/neu expres